SNHG12 and peripheral arterial disease: Given that diabetes is a major risk factor for the development of PAD (2, 6), progression of PAD, and major adverse limb events and cardiovascular events, we evaluated the role of Snhg12 silencing in a mouse model of obesity and diabetes.